Clinical trial
Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
NCT02063269
Study timeline
Study start (unknown)2014-02-01Date precision: month
Registry last updated2015-05-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
RivastigmineDRUG · verified · RxNorm: rivastigmine
Sponsors & collaborators
Seoul National University Hospitallead sponsor
Novartis Korea Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02063269 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.